Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Science (New York, N.Y.)|February 10, 1984
Phosphorylation events during Müllerian duct regressionJ M Hutson, M E Fallat, S Kamagata, et al.Journal of Cardiovascular Pharmacology|January 1, 1992
Detection by bioassay and specific enzyme-linked immunosorbent assay of phosphoramidon-inhibitable endothelin-converting activity in brain and endotheliumT D Warner, G P Budzik, J A Mitchell, et al.British Journal of Pharmacology|August 1, 1992
Regional differences in endothelin converting enzyme activity in rat brain: inhibition by phosphoramidon and EDTAT D Warner, G P Budzik, T Matsumoto, et al.Annals of Surgery|October 1, 1981
Mullerian inhibiting substance inhibits growth of a human ovarian cancer in nude miceP K Donahoe, A F Fuller, R E Scully, et al.Hybridoma|January 1, 1984
Production of monoclonal antibodies for affinity purification of bovine mullerian inhibiting substance activityH Shima, P K Donahoe, G P Budzik, et al.Peptides|September 1, 1990
Atrial peptides induce mast cell histamine releaseT J Opgenorth, G P Budzik, K W Mollison, et al.Molecular Pharmacology|April 1, 1995
Novel potent and selective inhibitors of inducible nitric oxide synthaseM Nakane, V Klinghofer, J E Kuk, et al.Biochemical and Biophysical Research Communications|April 14, 1987
Divergence of ANF analogs in smooth muscle cell cGMP response and aorta vasorelaxation: evidence for receptor subtypesG P Budzik, S L Firestone, E N Bush, et al.Canadian Journal of Physiology and Pharmacology|October 1, 1991
Truncated atrial natriuretic factor analogs retain full agonist activityW H Holleman, G P Budzik, E M Devine, et al.Molecular Pharmacology|December 1, 1990
Atrial natriuretic peptide antagonists: biological evaluation and structural correlationsT W von Geldern, G P Budzik, T P Dillon, et al.Pageof 4